These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 27194526)

  • 1. Chondroitin sulphate: a focus on osteoarthritis.
    Bishnoi M; Jain A; Hurkat P; Jain SK
    Glycoconj J; 2016 Oct; 33(5):693-705. PubMed ID: 27194526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
    Henrotin Y; Marty M; Mobasheri A
    Maturitas; 2014 Jul; 78(3):184-7. PubMed ID: 24861964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Bruyère O; Altman RD; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymeric chondroitin sulfate vs. monomeric glucosamine for the treatment of osteoarthritis].
    Menzel EJ
    Wien Med Wochenschr; 2000; 150(5):87-90. PubMed ID: 10838710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
    Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
    Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulfate and glucosamine sulfate associated to photobiomodulation prevents degenerative morphological changes in an experimental model of osteoarthritis in rats.
    Sanches M; Assis L; Criniti C; Fernandes D; Tim C; Renno ACM
    Lasers Med Sci; 2018 Apr; 33(3):549-557. PubMed ID: 29196833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis.
    Fox BA; Stephens MM
    Drugs Today (Barc); 2009 Jan; 45(1):21-31. PubMed ID: 19271029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment.
    Volpi N
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):119-27. PubMed ID: 15180452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy Treatment of Osteoarthritis with Combine Chondroitin and Glucosamine.
    Materkowski M
    Ortop Traumatol Rehabil; 2021 Jun; 23(3):239-244. PubMed ID: 34190047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.
    Lubis AMT; Siagian C; Wonggokusuma E; Marsetyo AF; Setyohadi B
    Acta Med Indones; 2017 Apr; 49(2):105-111. PubMed ID: 28790224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis.
    Kobayashi T; Notoya K; Nakamura A; Akimoto K
    Inflamm Res; 2005 Jun; 54(6):249-55. PubMed ID: 15973508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats.
    Terencio MC; Ferrándiz ML; Carceller MC; Ruhí R; Dalmau P; Vergés J; Montell E; Torrent A; Alcaraz MJ
    Biomed Pharmacother; 2016 Apr; 79():120-8. PubMed ID: 27044820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
    Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease.
    Kelly GS
    Altern Med Rev; 1998 Feb; 3(1):27-39. PubMed ID: 9600024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Literature Analysis Regarding the Combination of Substances: Glucosamine + Chondroitin in the Treatment of Osteoarthritis.
    Marczyński W; Tłustochowicz W; Tomaszewski W; Białecki J
    Ortop Traumatol Rehabil; 2022 Dec; 24(6):407-416. PubMed ID: 36734661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent?
    Stellavato A; Restaino OF; Vassallo V; Finamore R; Ruosi C; Cassese E; De Rosa M; Schiraldi C
    Adv Ther; 2019 Nov; 36(11):3221-3237. PubMed ID: 31494830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis.
    Bottegoni C; Muzzarelli RA; Giovannini F; Busilacchi A; Gigante A
    Carbohydr Polym; 2014 Aug; 109():126-38. PubMed ID: 24815409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals?
    Simánek V; Kren V; Ulrichová J; Gallo J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):51-6. PubMed ID: 16170388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):38-45. PubMed ID: 35394718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.